Liezl Gambe - Author on Grafa
All
Schrödinger partners with Lilly to unlock $1B AI "TuneLab" for biotechs
Schrödinger (NASDAQ:SGDR) announced a strategic collaboration with Eli Lilly and Company (NYSE:LLY) on Friday to integrate Lilly’s high-powered TuneLab™ AI platform directly into Schrödinger’s flagship enterprise software, LiveDesign.
Haemonetics expands vascular portfolio with €100M Vivasure deal
Haemonetics Corp. (NYSE:HAE) announced Friday it has acquired Vivasure Medical Limited, a Galway-based pioneer in vessel closure technology, in a move that significantly broadens its reach into the $2.5 billion global vascular closure market.
AnaptysBio deploys Anti-SLAPP defense in $2B GSK royalty feud
AnaptysBio (NASDAQ:ANAB) moved to dismantle a key legal pillar of GSK’s (NYSE:GSK) defense in the Delaware Chancery Court on Thursday, filing a motion to dismiss claims that the biotech "repudiated" its lucrative royalty agreement for the blockbuster-intent cancer drug Jemperli.







-640x358.jpg&w=1200&q=75)


